Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Aleksandra Tonkonogi, Axel C. Carlsson, Johanna Helmersson-Karlqvist, Anders Larsson & Johan Ärnlöv. (2016) Associations between urinary kidney injury biomarkers and cardiovascular mortality risk in elderly men with diabetes. Upsala Journal of Medical Sciences 121:3, pages 174-178.
Read now
Read now
Articles from other publishers (14)
Homare Shimohata, Yoshiki Iwaki, Marina Yamashita, Kentaro Ohgi, Hiroshi Maruyama, Mamiko Takayasu, Kouichi Hirayama & Masaki Kobayashi. (2021) The effect of sodium-glucose cotransporter 2 inhibitor (tofogliflozin) on renal tubular damage in diabetic patients without albuminuria. International Urology and Nephrology 54:8, pages 1907-1914.
Crossref
Crossref
Marwa Mohsen, Ahmed A. Elberry, Alaa Mohamed Rabea, Doaa Mahmoud Khalil, Mohamed E.A. Abdelrahim & Raghda R.S. Hussein. (2022) A New Clinical Utility for Tubular Markers to Identify Kidney Responders to Saxagliptin Treatment in Adults With Diabetic Nephropathy. Canadian Journal of Diabetes 46:2, pages 134-141.e2.
Crossref
Crossref
Viktor Rotbain Curovic, Tine W. Hansen, Mie K. Eickhoff, Bernt Johan von Scholten, Henrik Reinhard, Peter Karl Jacobsen, Frederik Persson, Hans-Henrik Parving & Peter Rossing. (2018) Urinary tubular biomarkers as predictors of kidney function decline, cardiovascular events and mortality in microalbuminuric type 2 diabetic patients. Acta Diabetologica 55:11, pages 1143-1150.
Crossref
Crossref
Subin Hwang, Jeeeun Park, Jinhae Kim, Hye Ryoun Jang, Ghee Young Kwon, Wooseong Huh, Yoon-Goo Kim, Dae Joong Kim, Ha Young Oh & Jung Eun Lee. (2017) Tissue expression of tubular injury markers is associated with renal function decline in diabetic nephropathy. Journal of Diabetes and its Complications 31:12, pages 1704-1709.
Crossref
Crossref
Carole G. Campion, Oraly Sanchez-Ferras & Sri N. Batchu. (2017) Potential Role of Serum and Urinary Biomarkers in Diagnosis and Prognosis of Diabetic Nephropathy. Canadian Journal of Kidney Health and Disease 4, pages 205435811770537.
Crossref
Crossref
Agnieszka Gala-Błądzińska, Paulina Dumnicka, Beata Kuśnierz-Cabala, Katarzyna Rybak, Ryszard Drożdż, Agnieszka Żyłka & Marek Kuźniewski. (2017) Urinary Neutrophil Gelatinase-Associated Lipocalin Is Complementary to Albuminuria in Diagnosis of Early-Stage Diabetic Kidney Disease in Type 2 Diabetes. BioMed Research International 2017, pages 1-7.
Crossref
Crossref
Girish N. Nadkarni, Veena Rao, Faramarz Ismail-Beigi, Vivian A. Fonseca, Sudhir V. Shah, Michael S. Simonson, Lloyd Cantley, Prasad Devarajan, Chirag R. Parikh & Steven G. Coca. (2016) Association of Urinary Biomarkers of Inflammation, Injury, and Fibrosis with Renal Function Decline: The ACCORD Trial. Clinical Journal of the American Society of Nephrology 11:8, pages 1343-1352.
Crossref
Crossref
Matthew D. Breyer & Katalin Susztak. (2016) The next generation of therapeutics for chronic kidney disease. Nature Reviews Drug Discovery 15:8, pages 568-588.
Crossref
Crossref
Tomás P. Griffin, William Patrick Martin, Nahidul Islam, Timothy O’Brien & Matthew D. Griffin. (2016) The Promise of Mesenchymal Stem Cell Therapy for Diabetic Kidney Disease. Current Diabetes Reports 16:5.
Crossref
Crossref
Temesgen Fiseha & Zemenu Tamir. (2016) Urinary Markers of Tubular Injury in Early Diabetic Nephropathy. International Journal of Nephrology 2016, pages 1-10.
Crossref
Crossref
R. M. Montero, A. Covic, L. Gnudi & D. Goldsmith. (2015) Diabetic nephropathy: What does the future hold?. International Urology and Nephrology 48:1, pages 99-113.
Crossref
Crossref
Joachim Jankowski, Joost P. Schanstra & Harald Mischak. (2015) Body fluid peptide and protein signatures in diabetic kidney diseases. Nephrology Dialysis Transplantation 30:suppl 4, pages iv43-iv53.
Crossref
Crossref
Ga-Young ParkChung-Hoon YuJun-Seop KimYun-Jeong KangOwen KwonJi-Young ChoiJang-Hee ChoChan-Duck KimYong-Lim KimSun-Hee Park. (2015) Plasma neutrophil gelatinase-associated lipocalin as a potential predictor of adverse renal outcomes in immunoglobulin A nephropathy. The Korean Journal of Internal Medicine 30:3, pages 345.
Crossref
Crossref
Gudeta D. Fufaa, E. Jennifer Weil, Robert G. Nelson, Robert L. Hanson, Joseph V. Bonventre, Venkata Sabbisetti, Sushrut S. Waikar, Theodore E. Mifflin, Xiaoming Zhang, Dawei Xie, Chi-yuan Hsu, Harold I. Feldman, Josef Coresh, Ramachandran S. Vasan, Paul L. Kimmel & Kathleen D. Liu. (2014) Association of urinary KIM-1, L-FABP, NAG and NGAL with incident end-stage renal disease and mortality in American Indians with type 2 diabetes mellitus. Diabetologia 58:1, pages 188-198.
Crossref
Crossref